Lynn Institute of Tulsa — Tulsa, Oklahoma

Lynn Institute of Tulsa is a clinical research site located in Tulsa, Oklahoma, United States 74135.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Lynn Institute of Tulsa has participated in 7 clinical trials with 4 currently active.

Therapeutic areas: COVID-19, Systemic Lupus Erythematosus, Irritable Bowel Syndrome.

Sponsors: Novavax, Galapagos NV, Arena Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lynn Institute of Tulsa?

Lynn Institute of Tulsa has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lynn Institute of Tulsa conducted?

Lynn Institute of Tulsa has 7 clinical trials on record, with 4 currently active. Their work covers COVID-19, Systemic Lupus Erythematosus, Irritable Bowel Syndrome.

Is Lynn Institute of Tulsa accredited by Crixeo Health?

Yes — Lynn Institute of Tulsa holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lynn Institute of Tulsa?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.